Regulatory Affairs Services

Regulatory QMS & Audit Support

GxP Quality & Regulatory Audit Services for Clinical Development and GMP Operations

In today’s stringent global regulatory environment, achieving and maintaining GxP compliance is critical for safeguarding product quality, patient safety, and market readiness. Techsol Life Sciences is a trusted partner for GxP Quality Management and Regulatory Audit Support, helping pharmaceutical, biotech, and medical device companies meet and exceed regulatory expectations across the clinical development and manufacturing value chain.

With over 15 years of global experience across U.S. FDA, EMA, MHRA, Health Canada, PMDA, and WHO regulatory frameworks, we provide end-to-end GxP audit services to ensure inspection readiness, risk mitigation, and lifecycle compliance.

Our Specialized GxP Audit Services

Techsol’s Specialized GxP Audit Services provide comprehensive compliance and quality oversight to ensure product quality, patient safety, and regulatory readiness. Our expertise includes Clinical Development Quality and GCP Compliance Audits, covering investigator sites, vendors, CROs, and trial processes to ensure GCP adherence and inspection readiness. We conduct GMP Compliance and Manufacturing Quality Audits to assess facilities, quality systems, and supply chain partners for global GMP alignment. In addition, our Integrated GxP Quality Management and Regulatory Audit Support includes cross-functional oversight, mock inspections, and end-to-end audit preparation to meet US FDA, EMA, MHRA, PMDA, and other international regulatory expectations.

We help sponsors and CROs maintain ICH-GCP compliance and inspection readiness across all phases of clinical development:

  • Clinical Trial Site Audits (Investigator Sites, Hospitals, and Study Centers)
  • Sponsor/CRO System Audits & Vendor Qualification Audits
  • Pharmacovigilance System Audits (GVP Compliance)
  • Clinical Trial Master File (TMF) and Data Integrity Audits
  • Inspection Readiness Programs for USFDA, EMA, and MHRA

Key Outcome: Identify gaps, strengthen data integrity, and ensure regulatory compliance for clinical programs.

Techsol provides comprehensive GMP audit services that align with 21 CFR Parts 210/211, EU GMP, WHO TRS, and ICH Q10 principles to maintain manufacturing and product release compliance:

  • API, Drug Product, and Biologics Manufacturing Facility Audits
  • Contract Manufacturing Organization (CMO) and Contract Testing Laboratory (CTL) Audits
  • Quality Management System (QMS) Gap Assessments
  • Data Integrity, Cleaning Validation, and Equipment Qualification Reviews
  • Pre-Approval Inspection (PAI) Readiness and CAPA Effectiveness Verification

Key Outcome: Ensure global supply chain reliability and regulatory approval readiness for commercial and clinical production.

We provide end-to-end audit lifecycle support, from planning and vendor qualification to regulatory inspection preparedness:

  • Development of Risk-Based Audit Programs (RBAP) aligned with ICH Q9 (R1) risk management principles
  • Mock Inspections & Gap Assessments to mitigate compliance risks proactively
  • CAPA Design and Effectiveness Verification for FDA, EMA, and MHRA audit findings
  • Digital Quality Metrics and KPIs for continuous improvement and regulatory intelligence monitoring
  • Training and Awareness Programs for internal and external stakeholders

Key Outcome: Achieve sustained inspection readiness, regulatory confidence, and faster time-to-market.

Value Proposition

Latest Regulatory Trends we consider for various GxP Audit services.

Regulatory Affairs Services

RIMS

Regulatory Strategy

regulatory-intelligence

Regulatory Intelligence

standard-quality-control-concept-m_23-2150041867

Process Standardization

hand-touching-digital-screen-with-data-visualization_23-2151964669

Regulatory Submissions

standard-quality-control-concept-m_23-2150041850

Gene Therapy Products

futuristic-business-scene-with-ultra-modern-ambiance_23-2151003762

Labeling and Artwork

workers-long-wooden-table_1262-810

HA Interactions & Country Support

group-people-working-out-business-plan-office_1303-15859

Pre-Submission Meetings: IND

medium-shot-team-sitting-table_23-2149271747

Pre-Submission Meetings: NDA

business-team-watching-discussing-presentation-laptop-male-executive-pointing-display_74855-7987

Pre-Submission Meetings: BLA

Latest Relevant Case Studies

Clinical-Study-Protocols-960x600-1

May 1, 2025

Specialized Regulatory Writing Solutions for Clinical Overviews in Combination Therapy Submissions

Media (3)

April 29, 2025

Developing a complex clinical trial Protocol for a CNS-based Psychiatric product …

June 10, 2025

Case study on regulatory strategy development and dossier submission support

Media (2)

June 10, 2025

Case study on medical device product registration in india

Latest Relevant Insights

Medical Device Registrations | Techsol Life Sciences

July 12, 2023

Mastering Medical Device Registrations: A Guide to Navigating Regulatory Pathways

Regulatory Compliance

June 21, 2021

Evolution in Global Pharmaceutical Regulatory Landscape & Notable Changes for Sponsors

Regulatory Consulting

June 5, 2021

Emerging Trends in Regulatory Affairs by Adapting to Latest Technological Advancements

MoCRA Cosmetics Regulatory Compliance FDA Techsol Life Sciences

Kanuary 29, 202

MoCRA Made Easy: A Comprehensive Guide to Cosmetic Safety Compliance

Edit Template

Send Us Your Requirement